Aptabio Therapeutics
₩5,130
0
-₩160-3.02% 06:30 Today
Statistics
Day High
5,480
Day Low
5,010
52W High
10,890
52W Low
3,870
Volume
43,783
Avg. Volume
66,584
Mkt Cap
137.9B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Jan 31Expected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q4 2022
-200
-143
-85
-28
Expected EPS
N/A
Actual EPS
-115
Financials
-874.09%Profit Margin
Unprofitable3.36BRevenue
-29.38BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AptaBio Therapeutics Inc. specializes in the discovery and advancement of innovative therapeutic agents. Its core activities encompass developing specific inhibitors for the NOX enzyme family and crafting aptamer-based anti-cancer medicines. Additionally, the company supplies a range of transfection reagents, including Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent, which are utilized for introducing DNA or RNA into eukaryotic cells. Key drug candidates in its pipeline include PX-115, designed to address diabetic nephropathy; APX-1004, intended for diabetic retinopathy; and APX-311, targeting non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics is headquartered in Yongin-Si, South Korea.
Show More
CEO
Jin Lee Soo
Employees
45
Country
South Korea
ISIN
KR7293780003
Listings
0 Comments
Share your thoughts
FAQs
What is Aptabio Therapeutics stock price today?▼
The current price of 293780.KQ is ₩5,130 KRW — it has decreased by -3.02% in the past 24 hours. Watch Aptabio Therapeutics stock price performance more closely on the chart.
What is Aptabio Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Aptabio Therapeutics stocks are traded under the ticker 293780.KQ.
Is Aptabio Therapeutics stock price growing?▼
293780.KQ stock has fallen by -14.93% compared to the previous week, the month change is a -34.23% fall, over the last year Aptabio Therapeutics has showed a -25.11% decrease.
What is Aptabio Therapeutics market cap?▼
Today Aptabio Therapeutics has the market capitalization of 137.9B
What were Aptabio Therapeutics earnings last quarter?▼
293780.KQ earnings for the last quarter are -115 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is Aptabio Therapeutics revenue for the last year?▼
Aptabio Therapeutics revenue for the last year amounts to 3.36B KRW.
What is Aptabio Therapeutics net income for the last year?▼
293780.KQ net income for the last year is -29.38B KRW.
How many employees does Aptabio Therapeutics have?▼
As of November 3, 2026, the company has 45 employees.
In which sector is Aptabio Therapeutics located?▼
Aptabio Therapeutics operates in the Health & Wellness sector.
When did Aptabio Therapeutics complete a stock split?▼
The last stock split for Aptabio Therapeutics was on August 24, 2021 with a ratio of 1:1.
Where is Aptabio Therapeutics headquartered?▼
Aptabio Therapeutics is headquartered in Yongin-si, South Korea.